HYPERIUM Tablet Ref.[51129] Active ingredients:

Source: Medicines Authority (MT)  Revision Year: 2021  Publisher: Les Laboratoires Servier, 50, rue Carnot, 92284 Suresnes cedex, France

Product name and form

Hyperium 1 mg, tablets.

Pharmaceutical Form

Tablet.

Qualitative and quantitative composition

Rilmenidine dihydrogen phosphate.

One tablet contains 1.544 mg rilmenidine dihydrogen phosphate corresponding to 1 mg rilmenidine base.

Excipient with known effect: lactose.

For the full list of excipients, see section 6.1.

List of Excipients

Lactose monohydrate
Microcrystalline cellulose
Paraffin
Sodium starch glycolate
Colloidal silica
Magnesium stearate
Talc
White beeswax

Pack sizes and marketing

Boxes of 10, 15, 20 or 30 tablets in blister packs (Aluminium/Polyamide/PVC).

Not all pack sizes may be marketed.

Marketing authorization holder

Les Laboratoires Servier, 50, rue Carnot, 92284 Suresnes cedex, France

Marketing authorization dates and numbers

MA 066/01301

Date of first authorisation: 06th February 2006
Date of latest renewal: 07th September 2010

Drugs

Drug Countries
HYPERIUM Brazil, France, Malta, Turkey
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈